Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000686303) titled 'Single and multiple dose study of XYL-2499 in healthy adults' on June 10.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: Xylo Bio
Condition:
Depression
Depression
Mental Health - Depression
Intervention:
Part A (Single Ascending Dose)
Part A will comprise a total of 6 sequential cohorts with up to 42 participants.
Cohort A1 will include 2 participants, of whom 1 will be randomised to receive XYL-2499 and 1 to placebo.
Cohorts A2 to A6 will each include 8 participants, with 6 participants randomized to r...